Skip to Main Content

Paper Details

Inhibition of endothelin-B receptor signaling synergizes with MAPK pathway inhibitors in BRAF mutated melanoma.
Oncogene
8
2021
Author NameAffiliation
Meenhard HerlynMolecular and Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute
Matthias GstaigerInstitute of Molecular Systems Biology, ETH Zurich
  • 1 - 2

Datasets

Release 1.2